Gene · 657
Papers3,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Endothelial β-arrestins regulate mechanotransduction by the type II bone morphogenetic protein receptor in primary cilia. | Pulm Circ | 2022 | 36532314 | PubTator, text mining | PubMed |
| Distinct gastric phenotype in patients with pathogenic variants in SMAD4: A nationwide cross-sectional study. | Endosc Int Open | 2022 | 36531685 | PubTator, text mining | PubMed |
| Histopathological spectrum of duodenal polyps in a retrospective ten-year study. | Discoveries (Craiova) | 2022 | 36518221 | PubTator, text mining | PubMed |
| Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis. | J Neuroinflammation | 2022 | 36510261 | PubTator, text mining | PubMed |
| Re-evaluation of the myoepithelial cells roles in the breast cancer progression. | Cancer Cell Int | 2022 | 36510219 | PubTator, text mining | PubMed |
| The Role of Bone Morphogenetic Protein Receptor Type 2 (BMPR2) and the Prospects of Utilizing Induced Pluripotent Stem Cells (iPSCs) in Pulmonary Arterial Hypertension Disease Modeling. | Cells | 2022 | 36497082 | PubTator, text mining | PubMed |
| A comparative mRNA- and miRNA transcriptomics reveals novel molecular signatures associated with metastatic prostate cancers. | Front Genet | 2022 | 36468011 | PubTator, text mining | PubMed |
| The roles of lncRNA functions and regulatory mechanisms in the diagnosis and treatment of hepatocellular carcinoma. | Front Cell Dev Biol | 2022 | 36467404 | PubTator, text mining | PubMed |
| Identification of TGF-β signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer. | Front Pharmacol | 2022 | 36467074 | PubTator, text mining | PubMed |
| The Growth Factors: Potential Biomarkers and Therapeutic Targets in Kidney Diseases. | Kidney Dis (Basel) | 2022 | 36466071 | PubTator, text mining | PubMed |
| An Unexpected Anemia Hiding a Rare Syndrome With Overlapping Phenotypes. | ACG Case Rep J | 2022 | 36447760 | PubTator, text mining | PubMed |
| Myofibroblast specific targeting approaches to improve fibrosis treatment. | Chem Commun (Camb) | 2022 | 36445310 | PubTator, text mining | PubMed |
| Unveiling the transcriptomic landscape and the potential antagonist feedback mechanisms of TGF-β superfamily signaling module in bone and osteoporosis. | Cell Commun Signal | 2022 | 36443839 | PubTator, text mining | PubMed |
| Application of second-generation sequencing in congenital pulmonary airway malformations. | Sci Rep | 2022 | 36443638 | PubTator, text mining | PubMed |
| Activin A directly impairs human cardiomyocyte contractile function indicating a potential role in heart failure development. | Front Cardiovasc Med | 2022 | 36440002 | PubTator, text mining | PubMed |
| An investigation of codon usage pattern analysis in pancreatitis associated genes. | BMC Genom Data | 2022 | 36434531 | PubTator, text mining | PubMed |
| Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer Patients. | Cells | 2022 | 36429046 | PubTator, text mining | PubMed |
| The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: results from routine clinical setting 2016-2021. | Front Genet | 2022 | 36425062 | PubTator, text mining | PubMed |
| ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression. | J Cell Mol Med | 2022 | 36420658 | PubTator, text mining | PubMed |
| Human papillomavirus infection can alter the level of tumour stemness and T cell infiltration in patients with head and neck squamous cell carcinoma. | Front Immunol | 2022 | 36420261 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/657/papers?page=23